Abstract
Background: Cross sectional studies have shown that 1-2% of patients with neurofibromatosis 1 (NF1) develop malignant peripheral nerve sheath tumours (MPNST). However, no population based longitudinal studies have assessed lifetime...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have